These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1212121)

  • 1. Topical mustine hydrochloride and psoriasis: a follow-up study.
    Purdy MJ
    Australas J Dermatol; 1975 Apr; 16(1):13-6. PubMed ID: 1212121
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical mustine hydrochloride and psoriasis.
    Purdy MJ
    Australas J Dermatol; 1973 Aug; 14(2):68-72. PubMed ID: 4759451
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous desensitization to mechlorethamine in patients with psoriasis.
    Pariser DM; Childers RC; Kechijian P; Halprin KM; Taylor JR
    Arch Dermatol; 1976 Aug; 112(8):1113-4. PubMed ID: 952529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of psoriasis by topical application of mechlorethamine. 118 reports].
    Revuz J; Mathoret C; Veret G; Touraine R
    Ann Dermatol Syphiligr (Paris); 1976; 103(5-6):653-8. PubMed ID: 138380
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical therapy of psoriasis with mechlorethamine.
    Zackheim HS; Arnold JE; Farber EM; Cox AJ
    Arch Dermatol; 1972 May; 105(5):702-6. PubMed ID: 5026678
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechlorethamine in psoriasis. Further attempts to induce immunological tolerance.
    Breza TS; Kechijian P; Taylor JR
    Arch Dermatol; 1975 Nov; 111(11):1438-9. PubMed ID: 1200651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis therapy. The effect of UV radiation on sensitization to mechlorethamine.
    Nusbaum BP; Edwards EK; Horwitz SN; Frost P
    Arch Dermatol; 1983 Feb; 119(2):117-21. PubMed ID: 6337558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
    Constantine VS; Fuks ZY; Farber EM
    Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of psoriasis with topical nitrogen mustard.
    Handler RM; Medansky RS
    Int J Dermatol; 1979 Nov; 18(9):758-61. PubMed ID: 511440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of topical mechlorethamine on skin lesions of psoriasis.
    Epstein E; Ugel AR
    Arch Dermatol; 1970 Nov; 102(5):504-6. PubMed ID: 5474112
    [No Abstract]   [Full Text] [Related]  

  • 11. Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis.
    Hoeger PH; Nanduri VR; Harper JI; Atherton DA; Pritchard J
    Arch Dis Child; 2000 Jun; 82(6):483-7. PubMed ID: 10833183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
    Ramsay DL; Parnes RE; Dubin N
    Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of patients with psoriasis by PUVA therapy and mechlorethamine.
    Mauduit G; Salle G; Schott AM; Thivolet J
    Br J Dermatol; 1986 Aug; 115 Suppl 31():82-5. PubMed ID: 3741804
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical mechlorethamine therapy for mycosis fungoides.
    Price NM; Constantine VS; Hoppe RT; Fuks ZY; Farber EM
    Br J Dermatol; 1977 Nov; 97(5):547-50. PubMed ID: 588466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
    Van Scott EJ; Kalmanson JD
    Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
    [No Abstract]   [Full Text] [Related]  

  • 16. [Local chemotherapy of psoriasis with nitrogen mustard].
    Touraine R; Revuz J; Boulvin F
    Ann Dermatol Syphiligr (Paris); 1973; 100(5-6):491-7. PubMed ID: 4802685
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical mechlorethamine for psoriasis. An attempt to avoid the development of sensitization by the use of a topical tolerogenic schedule.
    Price NM
    Int J Dermatol; 1979 Jun; 18(5):390-3. PubMed ID: 468460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PUVA therapy prevents sensitization to mechlorethamine in patients with psoriasis.
    Mauduit G; Silvestre O; Thivolet J
    Br J Dermatol; 1985 Nov; 113(5):515-21. PubMed ID: 2933055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Desensitization Protocol for Infliximab Hypersensitivity in a 13-Year Old Patient with Pustular Psoriasis.
    Behera SK; Selvarajan S; Mathews J; Shajil C; Das S; Munisamy M; Xavier AS
    Curr Drug Saf; 2019; 14(2):158-162. PubMed ID: 30659548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to induce tolerance to mechlorethamine hydrochloride.
    Leshaw S; Simon RS; Bear RL
    Arch Dermatol; 1977 Oct; 113(10):1406-8. PubMed ID: 911169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.